Evan K. Day

Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies

Mark C. Julian, Christine C. Lee, Kathryn E. Tiller et al. · Protein Engineering Design and Selection · 2015 · 42 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Glioblastoma Cell Resistance to EGFR and MET Inhibition Can Be Overcome via Blockade of FGFR-SPRY2 Bypass Signaling

Evan K. Day, Nisha G. Sosale, Aizhen Xiao et al. · Cell Reports · 2020 · 41 citations · Full text

Medicine, Cancer Biology, Oncology +16

ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers

Evan K. Day, Anne Campbell, Ashley Pandolf et al. · Molecular Therapy · 2020 · 28 citations · Full text

Medicine, Molecular Biology, Oncology +17

Disrupting the transmembrane domain–mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes

Elizabeth Bloch, Eden L. Sikorski, David Pontoriero et al. · Journal of Biological Chemistry · 2019 · 15 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition

Evan K. Day, Qing Zhong, Benjamin Purow et al. · Cancer Research · 2021 · 10 citations · Full text

Medicine, Cancer Biology, Oncology +16